Nucletron UK Ltd

Established in 1975, Nucletron is the knowledge-driven leader in radiation oncology committed to developing solutions focused on improving patient care.  Specializing in the development, manufacture, sales, service and support of the world's most innovative cancer treatment products, Nucletron actively partners with its customers to provide the most effective and efficient patient care options.

Nucletron also provides continuity of support throughout the life of the company's solutions in order to keep operating costs to a minimum, without compromising patient care.  All Nucletron solutions are designed to grow and change to consistently meet evolving clinical needs. Nucletron continuously invests in innovative research and development to create products that improve patients’ quality of care. This approach has made it possible to successfully treat body-site specific cancer, including gynecologic, breast, prostate, head and neck, skin surface, lung, and esophagus.

Critical to Nucletron is the establishment of close working relationships with each individual clinical team.  Many Nucletron employees have years of clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians.  This knowledge allows Nucletron to help its customers optimize the use of existing equipment, improve outcomes, control costs and manage resources.

Nucletron’s commitment to innovation is demonstrated by its ability to provide complete solutions. The company offers comprehensive products and services based around the following areas:

• Consultancy
• Imaging
• Treatment Planning
• Treatment Delivery
• Service, support , training and education

Each Nucletron system has the added advantage of working seamlessly with existing products, offering enhanced system integration with full connectivity through DICOM compliance.  Flexibility and open systems are important keys to optimizing clinical resources.
Headquartered in the Netherlands, Nucletron has offices in 16 countries and delivers tailored services and solutions to more than 3,000 institutions within 120 countries.

Brachytherapy

Brachytherapy is the placement of radioactive sources in or just next to a tumour. The word brachytherapy comes from the Greek “brachy,” meaning short distance. During brachytherapy, the radioactive sources may be left in place permanently or only temporarily, depending upon your cancer. To position the sources accurately, special catheters or applicators are used.

There are two main types of brachytherapy — intracavitary brachytherapy and interstitial brachytherapy. With intracavitary brachytherapy, the radioactive sources are put into a space near where the tumour is located, such as the cervix, the vagina or the oesophagus. With interstitial brachytherapy, the radioactive sources are put directly into the tissues, such as the prostate, breast or cervix.

Sometimes these brachytherapy procedure require anaesthesia and a brief stay in the hospital. Patients with permanent implants may have a few restrictions at first and then can quickly return to their normal activities. Temporary brachytherapy implants are left inside of your body for several hours or days. While the sources are in place, you will stay in a private room. Brachytherapy doctors, nurses and other medical staff will continue to take care of you, but they will take special precautions to limit their exposure to radiation.

Brachytherapy devices called high-dose-rate remote afterloading machines allow radiation oncologists to complete brachytherapy quickly, in about 10 to 20 minutes. Powerful radioactive sources travel through small tubes called catheters to the tumour for the amount of time prescribed by your radiation
oncologist. You may be able to go home shortly after the brachytherapy procedure. Depending on the area treated, you may receive several brachytherapy treatments over a number of days or weeks.

Most patients feel little discomfort during brachytherapy. If the radioactive source is held in place with a brachytherapy applicator, you may feel discomfort from the applicator. There are medications that can relieve this discomfort. If you feel weak or queasy from the anaesthesia, your radiation oncologist can give you medication to make you feel better.

Depending on the type of brachytherapy you received, you may need to take some precautions after you leave your treatment, particularly if you plan to be around young children or pregnant women. Ask your radiation oncologist or radiation oncology nurse about anything special you should know about brachytherapy.

Nucletron profile download (pdf)

Nucletron News

Nucletron announces 510(k) approval for Oncentra Simulation

Contact Information

Alex Kypriotis, Sales Manager (South)
Andy Clarke, Sales Manager (North)
Mark Charity, Sales Manager (SW & Eire)

Email: sales@uk.nucletron.com

Netherlands
Tel:    +31 (0) 318 557 133
Fax:   +31 (0) 318 550 485

United States
Tel:     +1 800 336 2249
           +1 410 312 4100
Fax:    +1 410 312 4199

Website:  www.nucletron.com